Marktprognose für Sarkopeniebehandlungen im asiatisch-pazifischen Raum bis 2030 – Regionale Analyse – nach Behandlungstyp (Vitamin-D- und Kalziumpräparat, Proteinpräparat, Vitamin-B12-Präparat und andere) und Vertriebskanal (Apotheken, Einzelhandelskanäle, Online-Kanäle und andere)
Produkte in klinischen Testphasen treiben den Markt für Sarkopeniebehandlungen im asiatisch-pazifischen Raum an
Einige große Akteure auf dem Markt für Sarkopeniebehandlungen konzentrieren sich zunehmend auf die Entwicklung von Medikamenten zur Behandlung von Sarkopenie. Derzeit werden neuartige Sarkopeniebehandlungen entwickelt und in klinischen Studien getestet. Einige dieser Produkte sind unten aufgeführt:
Tabelle 1. Medikament gegen Sarkopenie in klinischer Entwicklung
Firmenname Interventionen Bedingungen Phase klinischer Tests
Abbott Nutrition Medizinische Nahrung mit AN777
Orale Ernährungsformel Mangelernährung
Sarkopenie PHASE3
Nutricia Research Nahrungsergänzungsmittel: Bolus ONS A
Nahrungsergänzungsmittel: Bolus ONS B
Nahrungsergänzungsmittel: Bolus ONS C
Nahrungsergänzungsmittel: Bolus ONS D Sarkopenie PHASE1
Novartis Pharmaceuticals Medikament: Bimagrumab Sarkopenie PHASE2
McMaster University Verhaltensbezogen: Stufenreduktion Sarkopenie PHASE1
Metabolic Technologies Inc. Nahrungsergänzungsmittel: Placebo
Medikament: HMB plus Vitamin D
Verhaltensbezogen: Nicht-Sport
Verhaltensbezogen: Sport-Sarkopenie PHASE1
Merck Sharp & Dohme LLC Medikament: Vergleichspräparat MK-077
Medikament: Vergleichspräparat Placebo Sarkopenie PHASE2
Immunotec Inc. Nahrungsergänzungsmittel: Immunocal
Nahrungsergänzungsmittel: Casein Altern und Sarkopenie PHASE2
Lijun Yang Kombinationsprodukt: 3-monatige intensive Intervention Sarkopenie PHASE4
Regeneron Pharmaceuticals Medikament: REGN1033 (SAR391786)
Medikament: Placebo Sarkopenie PHASE2
Quelle: Firmenwebsites und Analyse von The Insight Partners
Daher bietet die wachsende Pipeline von Medikamenten, die sich in verschiedenen Stadien der klinischen Entwicklung befinden, erhebliche Chancen für das Wachstum des Marktes für die Behandlung von Sarkopenie.
Marktübersicht zur Behandlung von Sarkopenie im asiatisch-pazifischen Raum
Der Markt für Sarkopeniebehandlungen im asiatisch-pazifischen Raum ist in China, Indien, Japan, Südkorea, Australien und den Rest des asiatisch-pazifischen Raums unterteilt. Der asiatisch-pazifische Raum wird im Prognosezeitraum voraussichtlich die schnellste durchschnittliche jährliche Wachstumsrate auf dem Weltmarkt verzeichnen. Asien ist der bevölkerungsreichste Kontinent der Welt mit einer schnell alternden Bevölkerung, und in mehreren asiatischen Ländern treten Sarkopenie-bezogene Probleme immer häufiger auf. Asiaten führen einen völlig anderen Lebensstil und haben andere Ernährungsgewohnheiten als Menschen aus der westlichen Welt. In Asien ist Sarkopenie bei älteren Menschen bei Männern (Prävalenz 9,6–22,1 %) häufiger als bei Frauen (Prävalenz 7,7–21,8 %). Die Asian Working Group for Sarcopenia (AWGS) zielt darauf ab, die Sarkopenieforschung in Asien zu fördern.
Umsatz und Prognose des Marktes für Sarkopeniebehandlungen im asiatisch-pazifischen Raum bis 2030 (Mio. USD)
Segmentierung des Marktes für Sarkopeniebehandlungen im asiatisch-pazifischen Raum
Der Markt für Sarkopeniebehandlungen im asiatisch-pazifischen Raum ist nach Behandlungsart, Vertriebskanal und Land kategorisiert.
Basierend auf der Behandlungsart ist der Markt für Sarkopeniebehandlungen im asiatisch-pazifischen Raum in Vitamin-D- und Kalziumpräparate, Proteinpräparate, Vitamin-B12-Präparate und andere segmentiert. Das Segment Vitamin-D- und Kalziumpräparate hatte 2022 den größten Marktanteil an Sarkopeniebehandlungen im asiatisch-pazifischen Raum.
In Bezug auf die Vertriebskanäle ist der Markt für Sarkopeniebehandlungen im asiatisch-pazifischen Raum in Apotheken, Einzelhandelskanäle, Online-Kanäle und andere segmentiert. Das Segment Apotheken hatte 2022 den größten Marktanteil an Sarkopeniebehandlungen im asiatisch-pazifischen Raum.
Nach Ländern ist der Markt für Sarkopeniebehandlungen im asiatisch-pazifischen Raum in China, Indien, Japan, Australien, Südkorea und den Rest des asiatisch-pazifischen Raums segmentiert. China dominierte 2022 den Marktanteil bei der Behandlung von Sarkopenie im asiatisch-pazifischen Raum.
Abbott Laboratories, Bayer AG, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp und GSK Plc sind einige der führenden Unternehmen auf dem Markt für die Behandlung von Sarkopenie im asiatisch-pazifischen Raum.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Asia Pacific Market Analysis
5.1 Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 Asia Pacific Sarcopenia Treatment Market Forecast and Analysis
6. Asia Pacific Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Sarcopenia Treatment Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.7 Rest of Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.7.1 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.7.2 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Metagenics LLC
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Nestle Health Science SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Novartis AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Pfizer Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Sanofi SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Amway Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 GSK Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 14. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 15. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 16. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 17. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 18. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 21. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. Asia Pacific Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. Asia Pacific Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Asia Pacific Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Asia Pacific Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Asia Pacific Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 20. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 21. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 22. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Metagenics LLC
4. Nestle Health Science SA
5. Novartis AG
6. Pfizer Inc
7. Sanofi SA
8. Amway Corp
9. GSK Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.